Growth Metrics

Biohaven (BHVN) Change in Accured Expenses (2021 - 2026)

Biohaven has reported Change in Accured Expenses over the past 6 years, most recently at -$64.4 million for Q1 2026.

  • Quarterly results put Change in Accured Expenses at -$64.4 million for Q1 2026, down 2415.38% from a year ago — trailing twelve months through Mar 2026 was -$63.0 million (down 3880.55% YoY), and the annual figure for FY2025 was $4.2 million, down 47.73%.
  • Change in Accured Expenses reached -$64.4 million in Q1 2026 per BHVN's latest filing, down from -$12.8 million in the prior quarter.
  • Across five years, Change in Accured Expenses topped out at $33.1 million in Q2 2022 and bottomed at -$64.4 million in Q1 2026.
  • Median Change in Accured Expenses over the past 5 years was $2.8 million (2025), compared with a mean of -$3.1 million.
  • The largest annual shift saw Change in Accured Expenses surged 222.96% in 2025 before it tumbled 2415.38% in 2026.
  • Over 5 years, Change in Accured Expenses stood at $18.7 million in 2022, then crashed by 172.34% to -$13.5 million in 2023, then rose by 6.61% to -$12.6 million in 2024, then fell by 1.26% to -$12.8 million in 2025, then crashed by 403.55% to -$64.4 million in 2026.
  • Business Quant data shows Change in Accured Expenses for BHVN at -$64.4 million in Q1 2026, -$12.8 million in Q4 2025, and -$7.4 million in Q3 2025.